新的全球卵巢癌研究联盟与微软的“AI for Good”实验室携手，推出了首个超过100万美元的全球性资助计划，以提高生存率-动脉网

NEW GLOBAL OVARIAN CANCER RESEARCH CONSORTIUM JOINS FORCES WITH MICROSOFT'S AI FOR GOOD LAB TO LAUNCH FIRST-OF-ITS-KIND $1M+ GLOBAL GRANT TO IMPROVE SURVIVAL RATES

CISION 等信源发布 2025-05-08 19:00



可切换为仅中文







Four leading ovarian cancer research charities from four countries are funding a new

来自四个国家的四家领先的卵巢癌研究慈善机构正在资助一项新的

AI Accelerator Grant in partnership with Microsoft's AI for Good Lab to supercharge the next cancer research breakthrough

与微软的AI for Good实验室合作的AI加速器资助计划，以推动下一个癌症研究突破性进展

NEW YORK

纽约

，

May 8, 2025

2025年5月8日

/PRNewswire/ --

Today marks World Ovarian Cancer Day and the launch of the Global Ovarian Cancer Research Consortium — a first-of-its-kind alliance uniting four leading ovarian cancer research organizations across

今天是世界卵巢癌日，也是全球卵巢癌研究联盟的启动日，这个联盟是首次集结了四个领先的卵巢癌研究组织的联盟。

the United States

美国

，

Australia

澳大利亚

，

Canada

加拿大

, and the

，以及

United Kingdom

英国

。

Together, the Consortium is announcing its inaugural initiative: a game-changing

共同宣布联盟的首个倡议：一个改变游戏规则的举措

$1 million

100万美元

grant, with an additional

授予，另加

$1 million

100万美元

in compute support from

在计算支持方面

Microsoft's AI for Good Lab

微软的人工智能向善实验室

, to address the global challenge in ovarian cancer survival rates. Globally, 324,000 women are diagnosed with ovarian cancer and 207,000 women die from the disease each year. The Consortium's groundbreaking AI Accelerator Grant, is a bold new effort that will ignite a wave of innovation in AI-powered ovarian cancer research — bringing hope, and potentially life-saving breakthroughs, to women around the world..

，以应对全球卵巢癌存活率的挑战。在全球范围内，每年有 32.4 万名女性被诊断出患有卵巢癌，20.7 万名女性死于该疾病。该联盟开创性的 AI 加速器资助项目是一项大胆的新举措，将激发一波人工智能驱动的卵巢癌研究创新浪潮，为世界各地的女性带来希望，并可能带来挽救生命的突破。

The Consortium, formed in 2024, brings together leading ovarian cancer organizations –

该联盟于2024年成立，汇集了领先的卵巢癌组织——

Ovarian Cancer Research Alliance

卵巢癌研究联盟

在

the United States

美国

，

Ovarian Cancer Research Foundation

卵巢癌研究基金会

(

Australia

澳大利亚

Ovarian Cancer Canada

加拿大卵巢癌协会

, and

，以及

Ovarian Cancer Action

卵巢癌行动

(

United Kingdom

英国

）。

Their mission: to combine forces, resources, and determination to accelerate progress where it's desperately needed.

他们的使命：联合力量、资源和决心，在迫切需要的地方加快进展。

Now, with the support of Microsoft's technology and expertise, the Consortium is poised to rewrite the future of ovarian cancer care.

现在，凭借微软的技术和专业知识的支持，该联盟准备改写卵巢癌护理的未来。

Progress in ovarian cancer research is lagging dangerously behind other diseases

卵巢癌研究的进展危险地落后于其他疾病

. It's predicted that by 2050 the number of women around the world diagnosed with ovarian cancer will rise over 55% to 503,448 and the number of women dying from ovarian cancer is projected to increase to 350,956 each year. AI is already revolutionizing cancer diagnoses—from breast to brain, skin to thyroid—with stunning advances.

预计到2050年，全球被诊断出患有卵巢癌的女性人数将增加超过55%，达到503,448人，而每年死于卵巢癌的女性人数预计将增加到350,956人。人工智能已经在革新癌症诊断——从乳腺癌到脑癌，从皮肤癌到甲状腺癌——取得了惊人的进展。

。

But ovarian cancer has yet to feel the full power of this transformation. That changes now.

但是卵巢癌尚未感受到这一转变的全部力量。现在这将发生改变。

Audra Moran

奥德丽·莫兰

, President and CEO of

，总裁兼首席执行官

Ovarian Cancer Research Alliance (OCRA),

卵巢癌研究联盟 (OCRA)，

said:

说：

'For far too long, survival rates have barely budged, and women around the world continue to face devastating odds. We cannot afford to wait another decade for meaningful progress. At OCRA, we believe that artificial intelligence could hold the key to accelerating the breakthroughs we so desperately need—from earlier detection to better treatment options which is why we envisioned a grant of this global magnitude and scope specifically for AI.

“长久以来，存活率几乎毫无提升，全球女性仍在面对令人心碎的困境。我们无法再等待十年才能取得有意义的进展。在OCRA，我们相信人工智能可能成为加速我们迫切需要的突破的关键——从更早的检测到更好的治疗选择。这就是为什么我们设想设立一项具有如此全球规模和范围、专属于人工智能的资助计划。”

Attending the HHMT Forum gave us the opportunity to work with four outstanding global partners and we are thrilled to join forces with them and along with OCRA's longtime collaborators at Microsoft's AI for Good Lab to bring the power of technology to bear on one of the most urgent women's health challenges of our time.'.

参加HHMT论坛让我们有机会与四位杰出的全球合作伙伴合作，我们很高兴能与他们携手，并与OCRA长期合作的微软AI for Good实验室一起，将技术的力量应用于当今最紧迫的女性健康挑战之一。

With this urgent call to action, the Consortium is summoning the world's brightest minds to harness AI and tip the scales toward survival.

通过这一紧急行动号召，该联盟正在召集世界上最聪明的人才，利用人工智能，为生存争取更多机会。

Researchers will be asked to form teams that will include a representative from each of the four countries to compete for the new grant.

研究人员将被要求组成团队，每个团队包括来自这四个国家的代表，以竞争新的资助。

Microsoft is generously partnering on this grant to donate up to

微软在此拨款上慷慨合作，捐赠高达

$1m

100万美元

of in-kind Azure compute credits to the successful project through Microsoft's AI for Good Lab-partnership with OCRA. Microsoft's cloud computing power will enable the successful applicants to accelerate progress against ovarian cancer.

通过微软与OCRA的“AI for Good”实验室合作，为成功项目提供等值的Azure计算积分。微软的云计算能力将帮助成功申请者加快在卵巢癌研究方面的进展。

'New discoveries are needed to find lifesaving treatments for ovarian cancer, a cancer that tragically still has a low survival rate. Equipping leading researchers around the globe with powerful AI tools and computing resources will help accelerate their critical work, hopefully leading to breakthroughs that save women's lives.

“我们需要新的发现来找到拯救卵巢癌患者生命的治疗方法，这种癌症的存活率仍然很低。为全球领先的研究人员配备强大的人工智能工具和计算资源，将有助于加速他们的重要工作，希望可以带来拯救女性生命的突破。”

Microsoft's AI for Good Lab is proud to support ovarian cancer research through this grant.' said .

微软的人工智能向善实验室自豪地通过这项拨款支持卵巢癌研究。

Juan Lavista Ferres

胡安·拉维斯塔·费雷斯

, Microsoft Chief Data Scientist and Director of

，微软首席数据科学家兼

Microsoft's AI for Good Lab

微软的人工智能向善实验室

。

To learn more about the grant, visit

要了解有关拨款的更多信息，请访问

https://ocrahope.org/research/information-for-researchers/grant-programs/

OCRA is the largest global organization dedicated to fighting ovarian and gynecologic cancers while supporting patients and families. Since 1994, OCRA has invested

OCRA是全球最大的致力于抗击卵巢癌和妇科癌症并支持患者及其家属的组织。自1994年以来，OCRA已投入

$128 million

1.28亿美元

in research, helped secure

在研究中，帮助确保了

$3.8 billion

38亿美元

in federal research funding, and supports 95,000 individuals annually. Learn more at

在联邦研究资金方面，每年支持95,000人。更多信息请访问

www.ocrahope.org

。

SOURCE Ovarian Cancer Research Alliance